The Illumina MiSeq i100 Series, announced last fall, is the company's first customer-installable instrument since the iSeq. Illumina's latest offering was a brand-new challenge for Staff Software ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. On our ...

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus Systems.

Focused power on the MiSeq System Access focused applications such as targeted resequencing, metagenomics, small genome sequencing, targeted gene expression profiling, and more. MiSeq reagents ...

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs.

Caris Life Sciences has selected Illumina’s MiSeq sequencing system to support Caris’ evidence-based molecular profiling service. The MiSeq system will be deployed to enable simultaneous ...

Illumina, Inc. (NASDAQ:ILMN) today announced MiSeq™, a low-cost personal sequencing system that provides individual researchers a platform with rapid ...

Illumina, Inc. today announced the availability of its newest reagent kits for the MiSeq, the industry's most accurate and easiest-to-use benchtop sequencer. The improved chemistry doubles ...

The battle of the benchtop sequencers (between newcomer Ion Torrent, recently purchased for a staggering $725 million by Life Technologies, and the directly competing MiSeq instrument announced by ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. Through a ...